Immunosurveillance against tetraploidization-induced colon tumorigenesis

Cell Cycle

Volumn 12, Issue 3, 2013, Pages 473-479

  Boilève, Alice ^a,b,c   Senovilla, Laura ^a,b,c   Vitale, Ilio ^a,b,c   Lissa, Delphine ^a,b,c   Martins, Isabelle ^a,b,c   Métivier, Didier ^a,b,c   Van Den Brink, Stieneke ^d   Clevers, Hans ^d   Galluzzi, Lorenzo ^b,e   Castedo, Maria ^a,b,c   Kroemer, Guido ^a,b,e,f,g  

^a INSERM   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c UNIVERSITÉ PARIS SACLAY   (France)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f CENTRE DE RECHERCHE DES CORDELIERS   (France)

^g HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Apoptosis; Cell cycle; Cytochalasin D; Mitotic catastrophe; Nocodazole; P53

Indexed keywords

CALRETICULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CARCINOGENICITY; CELL SIZE; CELL STRUCTURE; CELL SURFACE; CELL SURVIVAL; COLON CARCINOGENESIS; CONTROLLED STUDY; CYTOPLASM; DIPLOIDY; IMMUNE DEFICIENCY; IMMUNOCOMPETENCE; IMMUNOSURVEILLANCE; INTESTINE CELL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; TETRAPLOIDY; TUMOR IMMUNITY; WILD TYPE;

MUS;

EID: 84875512598     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.23369     Document Type: Article

References (35)

1. Duelli D, Lazebnik Y. Cell-to-cell fusion as a link between viruses and cancer. Nat Rev Cancer 2007; 7: 968-76; http://dx.doi.org/10.1038/nrc2272
2. Fujiwara T, Bandi M, Nitta M, Ivanova EV, Bronson RT, Pellman D. Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells. Nature 2005; 437: 1043-7; http://dx.doi.org/10.1038/nature04217
3. Ganem NJ, Storchova Z, Pellman D. Tetraploidy, aneuploidy and cancer. Curr Opin Genet Dev 2007; 17: 157-62; http://dx.doi.org/10.1016/j.gde.2007.02. 011
4. Davoli T, Denchi EL, de Lange T. Persistent telomere damage induces bypass of mitosis and tetraploidy. Cell 2010; 141: 81-93; http://dx.doi.org/10. 1016/j.cell.2010.01.031
5. Vitale I, Galluzzi L, Senovilla L, Criollo A, Jemaa M, Castedo M, et al. Illicit survival of cancer cells during polyploidization and depolyploidization. Cell Death Differ 2011; 18: 1403-13; http://dx.doi.org/10.1038/cdd.2010.145
6. Ganem NJ, Pellman D. Limiting the proliferation of polyploid cells. Cell 2007; 131: 437-40; http://dx.doi.org/10.1016/j.cell.2007.10.024
7. Margolis RL. Tetraploidy and tumor development. Cancer Cell 2005; 8: 353-4; http://dx.doi.org/10.1016/j.ccr.2005.10.017
8. Vitale I, Galluzzi L, Castedo M, Kroemer G. Mitotic catastrophe: a mechanism for avoiding genomic instability. Nat Rev Mol Cell Biol 2011; 12: 385-92; http://dx.doi.org/10.1038/nrm3115
9. Davoli T, de Lange T. The causes and consequences of polyploidy in normal development and cancer. Annu Rev Cell Dev Biol 2011; 27: 585-610; http://dx.doi.org/10.1146/annurev-cellbio-092910-154234
10. Kwon M, Godinho SA, Chandhok NS, Ganem NJ, Azioune A, Thery M, et al. Mechanisms to suppress multipolar divisions in cancer cells with extra centrosomes. Genes Dev 2008; 22: 2189-203; http://dx.doi.org/10.1101/gad.1700908
11. Vitale I, Senovilla L, Jemaa M, Michaud M, Galluzzi L, Kepp O, et al. Multipolar mitosis of tetraploid cells: inhibition by p53 and dependency on Mos. EMBO J 2010; 29: 1272-84; http://dx.doi.org/10.1038/emboj.2010.11
12. Padilla-Nash HM, Hathcock K, McNeil NE, Mack D, Hoeppner D, Ravin R, et al. Spontaneous transformation of murine epithelial cells requires the early acquisition of specific chromosomal aneuploidies and genomic imbalances. Genes Chromosomes Cancer 2012; 51: 353-74; http://dx.doi.org/10.1002/gcc.21921
13. Senovilla L, Vitale I, Martins I, Tailler M, Pailleret C, Michaud M, et al. An immunosurveillance mechanism controls cancer cell ploidy. Science 2012; 337: 1678-84; http://dx.doi.org/10.1126/science.1224922
14. Galluzzi L, Vitale I, Abrams JM, Alnemri ES, Baehrecke EH, Blagosklonny MV, et al. Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ 2012; 19: 107-20; http://dx.doi.org/10.1038/cdd.2011.96
15. Sato T, Stange DE, Ferrante M, Vries RG, Van Es JH, Van den Brink S, et al. Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium. Gastroenterology 2011; 141: 1762-72; http://dx.doi.org/10.1053/j.gastro. 2011.07.050
16. Sato T, Vries RG, Snippert HJ, van de Wetering M, Barker N, Stange DE, et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 2009; 459: 262-5; http://dx.doi.org/10.1038/ nature07935
17. Jemaa M, Vitale I, Kepp O, Berardinelli F, Galluzzi L, Senovilla L, et al. Selective killing of p53-deficient cancer cells by SP600125. EMBO Mol Med 2012; 4: 500-14; http://dx.doi.org/10.1002/emmm.201200228
18. Shinkai Y, Rathbun G, Lam KP, Oltz EM, Stewart V, Mendelsohn M, et al. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D) J rearrangement. Cell 1992; 68: 855-67; http://dx.doi.org/10.1016/0092-8674(92) 90029-C
19. Senovilla L, Vitale I, Galluzzi L, Vivet S, Joza N, Younes AB, et al. p53 represses the polyploidization of primary mammary epithelial cells by activating apoptosis. Cell Cycle 2009; 8: 1380-5; http://dx.doi.org/10.4161/cc. 8.9.8305
20. Kroemer G, Galluzzi L, Kepp O, Zitvogel L. Immunogenic cell death in cancer therapy. Annu Rev Immunol 2012; In press; http://dx.doi.org/10.1146/ annurev-immunol-032712-100008
21. Baker DJ, van Deursen JM. Chromosome missegregation causes colon cancer by APC loss of heterozygosity. Cell Cycle 2010; 9: 1711-6; http://dx.doi.org/10. 4161/cc.9.9.11314
22. Caldwell CM, Green RA, Kaplan KB. APC mutations lead to cytokinetic failures in vitro and tetraploid genotypes in Min mice. J Cell Biol 2007; 178: 1109-20; http://dx.doi.org/10.1083/jcb.200703186
23. Dikovskaya D, Schiffmann D, Newton IP, Oakley A, Kroboth K, Sansom O, et al. Loss of APC induces polyploidy as a result of a combination of defects in mitosis and apoptosis. J Cell Biol 2007; 176: 183-95; http://dx.doi.org/10.1083/ jcb.200610099
24. Fridman WH, Pages F, Sautes-Fridman C, Galon j.The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer 2012; 12: 298-306; http://dx.doi.org/10.1038/nrc3245
25. Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pages C, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006; 313: 1960-4; http://dx.doi.org/ 10.1126/science. 1129139
26. Senovilla L, Vacchelli E, Galon J, Adjemian S, Eggermont A, Fridman WH, et al. Trial Watch: Prognostic and predictive value of the immune infiltrate in cancer. OncoImmunology 2012; 1: 1323-44; http://dx.doi.org/10.4161/onci.22009
27. Zitvogel L, Kepp O, Kroemer G. Immune parameters affecting the efficacy of chemotherapeutic regimens. Nat Rev Clin Oncol 2011; 8: 151-60; http://dx.doi.org/10.1038/nrclinonc.2010.223
28. Hoffman J, Kuhnert F, Davis CR, Kuo Cj.Wnts as essential growth factors for the adult small intestine and colon. Cell Cycle 2004; 3: 554-7; http://dx.doi.org/10.4161/cc.3.5.858
29. Jung P, Sato T, Merlos-Suarez A, Barriga FM, Iglesias M, Rossell D, et al. Isolation and in vitro expansion of human colonic stem cells. Nat Med 2011; 17: 1225-7; http://dx.doi.org/10.1038/nm.2470
30. Galluzzi L, Vitale I, Senovilla L, Eisenberg T, Carmona- Gutierrez D, Vacchelli E, et al. Independent transcriptional reprogramming and apoptosis induction by cisplatin. Cell Cycle 2012; 11: 3472-80; http://dx.doi.org/10.4161/ cc.21789
31. Lainey E, Sebert M, Thepot S, Scoazec M, Bouteloup C, Leroy C, et al. Erlotinib antagonizes ABC transporters in acute myeloid leukemia. Cell Cycle 2012; 11: 4079-92; http://dx.doi.org/10.4161/cc.22382
32. Castedo M, Coquelle A, Vivet S, Vitale I, Kauffmann A, Dessen P, et al. Apoptosis regulation in tetraploid cancer cells. EMBO J 2006; 25: 2584-95; http://dx.doi.org/10.1038/sj.emboj.7601127
33. Mouhamad S, Galluzzi L, Zermati Y, Castedo M, Kroemer G. Apaf-1 deficiency causes chromosomal instability. Cell Cycle 2007; 6: 3103-7; http://dx.doi.org/10.4161/cc.6.24.5046
34. Jemaa M, Galluzzi L, Kepp O, Boileve A, Lissa D, Senovilla L, et al. Preferential killing of p53-deficient cancer cells by reversine. Cell Cycle 2012; 11: 2149-58; http://dx.doi.org/10.4161/cc.20621
35. Lainey E, Wolfromm A, Marie N, Enot D, Scoazec M, Bouteloup C, et al. Azacytidine and erlotinib exert synergistic effects against acute myeloid leukemia. Oncogene 2012; In press; http://dx.doi.org/10.1038/onc.2012.469